Biorasi is a contract research organization (CRO) widely recognized for delivering success in complex clinical trials. This is possible through TALOS™, an innovative operating model that unifies systems and teams with a powerful project

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

CELLUSION AND CELREGEN A MEMBER OF FOSUN PHARMA, ENTER INTO EXCLUSIVE LICENSE AGREEMENT OF CLS001 FOR A CORNEAL ENDOTHELIAL CELL REGENERATIVE

Cellusion and Celregen | September 12, 2022

news image

Cellusion Inc. a Japanese regenerative medicine startup aiming to solve the global corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal Endothelial Cell Substitute from iPS Cells for bullous keratopathy novel treatment and Hangzhou Celregen Therapeutics Ltd. a member of Shanghai Fosun Pharmaceutical Co., Ltd. and focus on regenerative medicine and cell therapy and incubated by New Drug Fund of Fosun Health Capital announced an exclusive...

Read More

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

news image

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More

Pharmacy Market

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

news image

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

news image

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More
news image

Business Insights

CELLUSION AND CELREGEN A MEMBER OF FOSUN PHARMA, ENTER INTO EXCLUSIVE LICENSE AGREEMENT OF CLS001 FOR A CORNEAL ENDOTHELIAL CELL REGENERATIVE

Cellusion and Celregen | September 12, 2022

Cellusion Inc. a Japanese regenerative medicine startup aiming to solve the global corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal Endothelial Cell Substitute from iPS Cells for bullous keratopathy novel treatment and Hangzhou Celregen Therapeutics Ltd. a member of Shanghai Fosun Pharmaceutical Co., Ltd. and focus on regenerative medicine and cell therapy and incubated by New Drug Fund of Fosun Health Capital announced an exclusive...

Read More
news image

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More
news image

Pharmacy Market

VENENO TECHNOLOGIES, A NOVEL DRP DRUG DISCOVERY COMPANY, RAISES $2MILLION (¥200M YEN) IN SEED FUNDING ROUND

Veneno Technologies Co. Ltd. | January 27, 2022

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd. The funds raised will be used to strengthen the recruitment and organizational structure, to further develop the Company's proprietary peptide drug discovery platform technology, and invest in the research and develop...

Read More
news image

Pharmacy Market

IA COMMEMORATES 50 YEARS OF INNOVATION WITH LAUNCH OF NEW PHARMACY SOLUTIONS AT NACDS TOTAL STORE EXPO

iA | August 26, 2022

iA, a leading provider of pharmacy fulfillment and automation solutions, is celebrating 50 years of innovation at NACDS Total Store Expo. With a commitment to its heritage, iA’s mission has never wavered from streamlining operational processes through advancing technology. Today, iA continues to drive pharmacy industry innovations. From safe and accurate filling of prescriptions through the use of modern robotics, to production control software enhanced by warehouse manageme...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us